
Twitter (TWTR) Shares Slide after Elon Musk Announces That He is Walking Away from $44B Acquisition Deal
The decision Musk has taken to back out of the Twitter deal has caused the company’s shares to crash as a legal battle brews.
The decision Musk has taken to back out of the Twitter deal has caused the company’s shares to crash as a legal battle brews.
The Twitter board chair has hinted that the company may sue Elon Musk to enforce the agreement.
The US stock market futures will always be an indication of how healthy the economy is at the time.
As a result of the rules violation and failing to disclose the concentration of business operators, Alibaba and Tencent might face a potential fine of as much as 500,000 yuan ($74,688).
In their latest report, Private Shares Fund has marked down BlockFi series E warrants as totally worthless.
Buyers sometimes develop cold feet right after getting what they want. But Musk says his decision to back out of the Twitter deal is due to too many unanswered questions.
CJ ENM will leverage The Sandbox blockchain network to bring immersive content experiences to its massive user base in the Metaverse.
After announcing the takeover bid, Musk and his team requested data regarding the spam accounts on the platform.
In addition to halting the need for Facebook credentials, Meta is also changing its marketing strategy.
Two major interest rate hikes are possible in the next three months. Will this push the US economy into recession?
The current lawsuit casts a shadow of more doubt over the survival of Celsius network.
The demand weakness and challenges facing semiconductor firms set the pace for the Samsung 2022 Q2 earnings guidance.
Over the last week’s trading sessions, US stocks are showing a good uptick. Analysts think that the drop in the flow of negative news has helped the market to revive its lost grounds.
The first of the three executives who left JPMorgan is Samuel Shah. Shah, until his exit, was head of the bank’s Ideation and Digital Innovation department.
The regulatory concerns associated with the potential deal between Merck and Seagen may attract antitrust scrutiny from regulators.